DV Management News
When performance counts, science matters
Director, Global Research and Marketing
Dairy nutritionists and producers now have more proof of the significant role Diamond V Original Product plays in supporting dry matter intake (DMI) during the early lactation phase. The U.S. Food and Drug Administration (FDA) recently granted Diamond V the functional claim "... helps support the dry matter intake of dairy cows when fed as part of a total mixed ration during the first 70 days of lactation." This makes Diamond V the only company in the category with an FDA accepted functional claim for dairy DMI.
We're proud of this latest validation of Diamond V's microbial-based fermentation technology; it lends even stronger credence to the hundreds of field trials and peer-reviewed published studies we've conducted over the decades. The reason we have such a long-standing emphasis on research is simple: Quality measurable science provides the strongest possible evidence that a product and technology will produce the results that the market requires for ongoing production and profit growth.
This claim is specific to the dairy business, but we wanted to share it with other segments of the industry. We are glad the FDA has seen fit to further validate the science that we know has been making a difference for many years.
As always, we appreciate your readership of PoultryAdvisor and welcome your input.
Kind regards,
Mike
|
Research Review
You're invited to our PSA abstracts presentations
Manager, Global Poultry Research & Technical Support
Diamond V
Diamond V has two abstracts that will be presented at the 2013 Poultry Science Association meetings in San Diego, California this month (July 22-24). The abstracts include research results from a broiler coccidia challenge study at Southern Poultry Research and in vitro research evaluating the effects of Original XPC on Salmonella Arizonae and Heidelberg growth.
Abstract # 172; Oral presentation, Pacific Salon 3; Wednesday, July 24 at 1:45 PM
Title: Effects of feeding Original XPCTM and Salinomycin during a coccidia challenge in broilers
Overview: Cobb broiler chicks were fed no additives (NC & PC), Original XPC, Salinomycin (SAL), or the combination (XPC+SAL) through 28d. Other than a non-challenge, no additive fed group (NC), the birds were challenged at 21d with E. acervulina (EA), E. maxima (EM), and E. tenella (ET). Feeding XPC, SAL, and XPC+SAL significantly improved performance and reduced lesion scores in the upper (EA), mid (EM), and lower (cecal; ET) sections of the gut. Additive improvements in body weight gain and feed conversion were observed when XPC+SAL combination was fed, compared to each fed individually. Results of this research show that XPC can be added to further improve existing anti-coccidia programs.
See abstract here
Title: Effects of Original XPCTM on growth of Salmonella Arizonae and Heidelberg in a complex fecal microbial population
Overview: In vitro research was conducted at the Diamond V Research and Innovation Center using the Intestinal Activity Modifier Model (IAMM). Fresh turkey or laying hen feces was collected to make two different fecal inocula, containing the live microbiota found in the lower gut. Predigested feed, with or without XPC, was then added.
Salmonella Arizonae (SA) or Salmonella Heidelberg (SH) was added to the turkey or laying hen inocula, respectively, and incubated for 24 hours. Volatile fatty acid (VFA) production (indicator of microbial population) and SE growth was measured. Improvements in VFA production, particularly butyrate, in both fecal inocula were observed with the addition of XPC. The addition of XPC to turkey or laying hen fecal inocula suppressed SA or SH growth, respectively.
|
|
 Diamond V
The Trusted Experts in Nutrition and Health™
|
2525 60th Ave. SW
Cedar Rapids, Iowa 52404
1-800-373-7234
Copyright 2013 Diamond V - All rights reserved
|
